UK small-cap RNS · 30 Sep 2026

Proposed acquisition of GEM Newco Limited (“Gem New Co”)

The 2026 interims will miss the 30 September deadline because the 2025 accounts are still unpublished. The shares stay suspended and the reporting delay now covers two periods, adding to funding stress.

Update on Publication of Results for the Year Ended 31 March 2026

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces its unaudited interim results for the six months ended 30 June 2026 (“H1 2026”).

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces its intention to undertake a proposed equity fundraising with institutional and other investors (the “Proposed Fundraise”).

Nativo Resources plc (LON:NTVO), the precious metals company with gold mining and processing interests in Peru, announces that Non-Executive Director, Andrew Donovan, has purchased 4,000,233 Ordinary Shares of 0.15p each ("Ordinary Shares") in the Company.

8M revenue (+19%) and cash collections (+12%) are up and receivables are down, but net debt rose to US$701.3m and group production remains below FY 2025. Shares stay suspended.

Renewed irrevocable buyback instruction with Peel Hunt, with shares cancelled, continues the repurchases made while the discount to NAV was wide (43.4% at year end). Size and price limits are not stated.

A second AIM deadline is missed because the FY2025 accounts are still unpublished, so the shares stay suspended with no date for relisting and the delisting risk in the cash shell grows.

Interim results show JV progress at Munni Munni and Elizabeth Hill, which cuts direct funding needs. A US$6.7m non-cash Hancock impairment, however, writes down the iron ore asset that funding depends on.

Distressed raise of at least £4.0m at an anticipated 0.3p a share, needed to pay overdue creditors after Mace cash delays; likely heavily dilutive and conditional on a shareholder vote.

Completes the sale of the Czech Acrylate Monomers operating company on the terms announced 19 June 2026. The business was loss-making in H1 (EBITDA £(0.4)m), so the portfolio is simpler. Price and buyer are not given here.

FY26 loss after tax of A$165.7m, driven by seven losing concluded cases, leaves net liabilities of A$53.6m against net assets of A$114.4m a year earlier.

Interims show Fibermode wind-down complete and a recapitalised cash shell under a new board, but zero revenue and cash of only £13k at 30 June. Success now depends on finding an RTO target and raising more capital.

Audited FY26 results give no financial figures in the text provided, but the report shows asset sales funding HY-Range, 3% Phase 2 hydrogen readings and a seismic contractor chosen, with no new shares issued.

Preferred bidder status for a long-term Scotland DRS logistics contract with Re.Group extends Environmental Services; it is not yet signed and no value is stated, so the financial impact is unknown.

On 2 July 2026 the Company released an announcement recommending final ordinary dividend for 2026 of 2.8 euro cents per share and an additional special dividend of 0.3 euro cents per share, totalling 3.1 euro cents per share.

Net loss narrowed to A$11.6m from A$15.3m and cash rose to A$16.0m, but costs such as employee benefits rose and the Tiris FID has slipped to Q4 2026 with financing still unsigned.

The Company is pleased to announce its results for the six months ended 30 June 2026.

The plc is still in administration, so the going-concern failure persists. It has missed the AIM deadline for H1 2026 results, FY25 accounts remain unpublished, and any exit depends on an unconcluded investment.

Annual results for the year to 30 June 2026 are dominated by the Kiri/Equinaire foreclosure dispute and the MMCI ownership fight, which put the asset behind MCB at risk despite DFS progress.

Interim balance sheet repaired (net assets £3.35m, cash £1.20m after raise and note conversions) and a new silver discovery, but the profit is a £0.63m finance gain, the operating loss widened, and the resource has slipped to Q4.

Interims show operational progress (FEED awarded, export route agreed, Macquarie at term sheet) and much lower admin costs, but cash is £7.1m and the farm-out has restarted, so Temaris funding is still unresolved.

H1 free cash flow of US$54.7m still funds La India, but profit before tax rose to US$26.7m while FCF and EBITDA fell and La India's budget rose to c.US$180m.

Monthly income rose in both segments (Technology £46,853 from £34,332; Financial £17,129 from £13,940), the first rise after months of falls, but income is tiny against £41.7m NAV; NAV rebounded to 23.5p.

Half-year loss widened to £656,355 from £288,713 on adviser costs for the reverse takeover. Cash of £728,659 is funded by loan notes, the shares are still suspended and the deal is not agreed.

HY26 confirms the slide: infrastructure income fell to £0.6m from £2.9m and NAV per share to 18.07p. The August NAV rebound to 23.5p (+29.9%) is the offset, though it comes from market moves, not income.

Forgent plc (AIM: FORG), the Australian-focused critical and precious minerals explorer, announces that it has raised £500,000 (before expenses) by way of a direct subscription (the "Subscription") with an existing high net worth shareholder for 4,166,666,667 …

Interim results show H1 revenue of €0.4m against €2.7m and an EBITDA loss of €2.8m, with net debt of €0.6m. These are the trading shortfall already flagged, now confirmed. This is a results report, not a new warning.

Ghummud hosting delivers maiden revenue of £0.16m, but the loss doubled to £0.86m and cash fell to £0.17m, so going concern depends on a funding deal that is not yet signed.

The ICC Tribunal upheld the $196.5m Ghana tax assessment on insurance proceeds and put the 100% penalties outside the Petroleum Agreements' protections. Tullow is exposed to a cash liability, set against $1.4bn net debt and FCF guidance of $170-250m.

Underlying growth of 18.8% and EBITDA up 16.6% are solid, but Arizona Medicaid holds reported growth to 10.8%, Medicaid reported growth to 2.4% and margin to 10.1%. Guidance is only reconfirmed.

URU Metals Limited (“URU” or the “Company”) is pleased to announce the Company has raised £1.25 million before expenses, through a placing of 50,000,000 new ordinary shares of no nominal value each in the capital of the Company (the ‘Placing Shares’) at a …

H1 matched management's expectations, with revenue, profit before tax and free cash flow up and net debt at its lowest since the 2014 IPO, so the fall in net debt continues.

Beacon Energy (AIM:BCE), announces its half-yearly report for the six months ended 30 June 2026.

Interim results for the six months ended 31 July 2026

ARR is up 10% year on year to £7.9m and £8.4m post-period, but H1 new contracted ARR fell to £0.3m from £1.0m, so growth relies on post-period wins.

H1 2026 results confirm NDA 1 is funded with first oil still Q1 2028, and show a US$788m NPV uplift and a US$200m raise completed. OSX-1 terms with Navitas and the Italian approval are still open.

Interims for H1 2026 show the US phosphate business as a discontinued operation held for sale; no financial figures are given here, so the focus is the pivot to copper already announced.

Interim results show Kabwe drilling completed and well funded, but zero Rukwa coal sales, a restart still unfunded and a GMI loan restructured into convertible paper at 4p, which dilutes shareholders.

The 50-60% full-year revenue growth guidance was set in May and is only confirmed here, not raised; Q3 YTD growth of about 50% sits at the bottom of that range.

H1 revenue fell to €1.2m from €1.8m and the loss widened to €0.94m from €0.06m on lower margin and higher finance costs. The company calls the revenue drop timing and expects full-year revenue broadly in line with the prior year.

Raises only £242k at a 25% discount, issuing 1.7bn shares to cover audit, tax and working capital; this dilutes holders and shows the stretched cash position, with DRC housing cash delayed.

Preliminary results for the year ended 31 May 2026

Audited FY to March 2026 results report exploration progress at Ferber and Kalahari and the Sandfire sale, but Luansobe's licence loss and the legal proceedings put the 75% interest at risk.

FY26 adjusted EBIT of c.£6.0m beats the £5.5m consensus, after April's guidance of only 'in line'. Cash conversion also left net debt better than anticipated, so the turnaround is running ahead of plan.

Not a warning: revenue was in line with expectations and the Board confirms 2026 Adjusted EBITDA market expectations, but from a lower revenue base after a year of falling profit.

Interim Results for the six months ended 30 June 2026

Underlying profit slipped to £1.3m and NTA fell to 47.6p on a £2.5m revaluation deficit, but debt is falling, the dividend is covered and capital returns are now flagged for 2027.

Interim loss widened to £284,101 on deal costs, but the April fundraise lifted cash to £1.17m and the directors see adequate resources, with the shares still suspended.

The period since the publication of the Company's previous financial results on 17 June 2026 has been one of significant change and progress for the Company.

Second upgrade in about two weeks: the Board now expects FY26 revenue and EBITDA materially ahead of consensus that has already risen to £197.6m and £57.2m, from £175.2m and £50.7m, as Wardogs and Hell Let Loose: Vietnam beat plans.

H1 revenue rose 45% to £0.76m at a steady 60% margin and the loss narrowed slightly, but trials are converting slower than hoped and cash fell to £0.85m from £1.49m at December, so funding pressure is rising.

Interims show £4.3m raised in H1 funding the West Newton A-2 recompletion in Q4 2026, plus a £0.6m gain and £5.0m contingent receivable from the Colle Santo sale to Beacon.

Share code on JSE: GML (General Segment of JSE Main Board) / AIM:GEM

Adjusted EBITDA for FY27 now expected at no less than £3.75m, ahead of market expectations, after the FY26 recovery to £2.65m. Margin and fixed-cost focus drive it while revenue stays in line.

Progress on the Angola deals and a renewables sale process with multiple offers, but only US$4.7m cash at 30 June 2026 and oil cashflow not expected until 2027.

The H1 fall (revenue -38.2%, adjusted EBITDA -68.7%) is against a sensor-driven 2025 peak, now fully recognised. Cash is up to $14.9M and debt is down. CSP lost money in H1 but is guided to a small full-year profit.

Platform revenue up 32% and gross margin up to 33.5%, but the loss from continuing operations widened to €1.57m on marketing and development spend, with cash of only €7k.

H1 revenue +10% and EBITDA +48% to £1.0m match expectations with guidance kept, but ARR growth slowed to 14% from 23% and free cash flow fell to £0.7m.

Strategic transformation establishes Thalia as a clinical-stage RNA therapeutics company with a diversified development pipeline

Interim Results for the six months ended 30 June 2026

Restates the 9 September sale of most of Mechanical Engineering to a Cerberus affiliate for up to £1.1bn cash; completion still expected Q1 2027, with no UK corporation tax on the gain, so more proceeds are available for shareholders.

With all assets sold, no income was earned in H1 2026 against €0.42m net operating income a year earlier. Recurring EBITDA fell to a €0.2m loss and the company is an empty shell.

West Kytlim brought forward £2.3m of revenue and about £0.8m profit in H1 (nil revenue in 1H2025). Total comprehensive income is a £0.4m loss on FX translation, and no Arctic financing news.

Shares are suspended from 1 October 2026 because FY26 accounts will miss the AIM Rule 19 deadline. Investors cannot trade until publication, which adds to the pressure from the restructuring and funding strain.

Company now expects full-year trading ahead of market expectations after a strong first half, moving beyond the earlier 'confident' stance; summer weather and World Cup helped, so part of the gain may be one-off.